5 not yet recruiting. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Not yet recruiting 5 |
Follow Li Min: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SEED-CRYO: Sequential 125I Seed Implantation Followed by Cryoablation vs Single-Modality Local Therapy in Unresectable Solid Tumors Iodine-125 (125I) Seed Implantation, cryoablation, Sequential 125I Seed Implantation Followed by Cryoablation - Unresectable Solid Tumors | Phase 2 | Not yet recruiting | Li Min | 150 | 2026-02-01 | 2026-03-04 |
| Lesion-Allocated Therapy for Multiple Metastases and Tumor-Zoned Treatment for Bulky Tumors: A Phase II Study of Iodine-125 Seed Implantation Combined With Cryoablation in High-Burden Metastatic Disease Iodine-125 (125I) Seed Implantation (Low-Dose-Rate Brachytherapy), cryoablation, Lesion Allocation and Tumor Zoning Strategy - High-Burden Metastatic Solid Tumors | Phase 2 | Not yet recruiting | Li Min | 90 | 2026-02-01 | 2026-02-27 |
| 125I Seed Brachytherapy Combined With Immunotherapy for Primary, Recurrent, or Metastatic Malignant Tumors Immune Checkpoint Inhibitors, 125I Seed Implantation - Malignant Tumors | Phase 2 | Not yet recruiting | Li Min | 90 | 2026-01-01 | 2026-01-06 |
| Image-Guided 125I Seed Implantation Plus Standard Systemic Therapy for Patients With Multiple Metastatic Lesions Standard-of-Care Systemic Therapy, Iodine-125 (125I) Seed Implantation - Metastatic Solid Tumors | Phase 2 | Not yet recruiting | Li Min | 120 | 2026-01-01 | 2026-01-12 |
| 125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer Standard-of-Care Systemic Therapy, 125I Seed Implantation - Oligometastatic Disease | Phase 2 | Not yet recruiting | Li Min | 90 | 2026-01-01 | 2026-01-12 |
Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Neoplasms (1) · Recurrence (1)
Iodine-125 (3) · Cryosurgery (2) · Immune Checkpoint Inhibitors (1)
China (5)
Min Li (2) · Min Li, Dr. (1) · Min Li, M.D. (1)